Arius Research Overview
- Year Founded
-
1999

- Status
-
Acquired/Merged
- Employees
-
31

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$180M
Arius Research General Information
Description
Developer of anticancer monoclonal antibodies therapeutics. The company offers a proprietary technology platform that identifies monoclonal antibodies targeting a variety of cancer indications and engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia and melanoma.
Contact Information
Website
www.ariusresearch.comCorporate Office
- 55 York Street
- 16th Floor
- Toronto, Ontario M5J 1R7
- Canada
Corporate Office
- 55 York Street
- 16th Floor
- Toronto, Ontario M5J 1R7
- Canada
Arius Research Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 23-Sep-2008 | $180M | Completed | Generating Revenue | ||
4. PIPE | 01-Mar-2006 | Completed | Generating Revenue | |||
3. PIPE | 19-Sep-2005 | Completed | Generating Revenue | |||
2. PIPE | 21-Oct-2004 | $2.02M | $5.2M | Completed | Generating Revenue | |
1. IPO | 10-May-2000 | $3.38M | $3.17M | Completed | Generating Revenue |
Arius Research Patents
Arius Research Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20100158801-A1 | Methods for the treatment of acute myeloid leukemia | Inactive | 23-Dec-2008 | ||
US-20100015045-A1 | Cancerous disease modifying antibodies | Inactive | 17-Jul-2008 | ||
US-20090191119-A1 | Cancerous disease modifying antibodies | Inactive | 28-Jan-2008 | ||
US-20090191120-A1 | Cancerous disease modifying antibodies | Inactive | 28-Jan-2008 | ||
US-20090191197-A1 | Cancerous disease modifying antibodies | Inactive | 28-Jan-2008 | C07K16/30 |
Arius Research Signals
Arius Research Former Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
BVF Partners | Hedge Fund | Minority | ||
Efficacy Capital | Venture Capital | Minority | ||
National Research Council Canada | Government | Minority | ||
OrbiMed | Growth/Expansion | Minority | ||
Xmark Asset Management | Venture Capital | Minority |
Arius Research FAQs
-
When was Arius Research founded?
Arius Research was founded in 1999.
-
Where is Arius Research headquartered?
Arius Research is headquartered in Toronto, Canada.
-
What is the size of Arius Research?
Arius Research has 31 total employees.
-
What industry is Arius Research in?
Arius Research’s primary industry is Discovery Tools (Healthcare).
-
Is Arius Research a private or public company?
Arius Research is a Private company.
-
What is the current valuation of Arius Research?
The current valuation of Arius Research is
. -
What is Arius Research’s current revenue?
The current revenue for Arius Research is
. -
How much funding has Arius Research raised over time?
Arius Research has raised $26.4M.
-
Who are Arius Research’s investors?
BVF Partners, Efficacy Capital, National Research Council Canada, OrbiMed, and Xmark Asset Management have invested in Arius Research.
-
When was Arius Research acquired?
Arius Research was acquired on 23-Sep-2008.
-
Who acquired Arius Research?
Arius Research was acquired by Norda Stelo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »